Comunicados de prensa European Medicines Agency (EMA) — News Salud y ciencias de la vida — Feed RSS y monitoreo en vivo
PPN World indexa los comunicados de prensa de European Medicines Agency (EMA) — News y archiva cada publicación. Esta fuente está en silencio desde el 13 de noviembre de 2026 — sus 70 comunicados indexados siguen disponibles, y una alerta te avisará en cuanto vuelva a publicar.
Correo diario gratuito
Lo que llega mañana
Los grandes eventos mundiales de mañana, de la agenda de PPN World (bancos centrales, datos, elecciones, cumbres), cada tarde a las 17:00 UTC.
Un correo al día. Sin cuenta. Baja con un clic.
Sobre este feed
European Medicines Agency (EMA) — News forma parte de los más de 1,400 feeds de comunicados que PPN World monitorea de forma continua — una fuente en inglés centrada en el sector Salud y ciencias de la vida, clasificada entre nuestras fuentes internacionales. Cada comunicado se deduplica, se geolocaliza y se enriquece con un resumen de IA, y puedes añadir alertas de búsquedas guardadas sobre cualquier palabra clave que publique. El comunicado más reciente de nuestro índice se publicó el 13 de noviembre de 2026; la fuente está en silencio desde entonces.
Sigue European Medicines Agency (EMA) — News en tiempo real en PPN World
Cada comunicado de European Medicines Agency (EMA) — News llega al cockpit segundos después de publicarse — deduplicado, clasificado, con alertas de búsquedas guardadas y resúmenes con IA, junto a más de 1,400 feeds.
Crear cuenta gratis →Comunicados de European Medicines Agency (EMA) — News — archivo
- Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 November 2026hace 9 d
Seven new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended seven medicines for approval at its November 2026 meeting.The committee…, CHMP statistics Key figures fro…
- Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 3-5 November 2026hace 15 d
CVMP opinions on veterinary medicinal products Further to the re-examination of the opinion adopted by the Committee during its June 2026 meeting, the Committee adopted a…
- PRAC starts review of depression and anxiety medicine Deanxit (flupentixol/melitracen)hace 23 d
EMA’s safety committee (PRAC) has started a review of Deanxit, a fixed-dose combination medicine for treating depression and anxiety, following reports of serious neurological…
- Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26 - 29 October 2026hace 23 d
PRAC starts review of depression and anxiety medicine Deanxit (flupentixol/melitracen)PRAC has started a review of Deanxit, a fixed-dose combination medicine for treating…, Agenda Agenda of the PRAC m…
- EMA closed on All Souls' Day, 2 Novemberhace 24 d
EMA’s office is closed on Monday 2 November, to mark All Souls' Day. The office reopens at 08:30 on Tuesday 3 November.The product emergency hotline is available outside…
- AMA and EMA issue joint guidance on Ebola vaccine developmenthace 30 d
EMA’s Emergency Task Force (ETF) and the African Medicines Agency (AMA) have published a joint position paper to support the timely start of clinical trials for potential…
- Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 October 2026hace 37 d
Six new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended six medicines for approval at its October 2026 meeting.Rasonque (daraxonrasib)…, CHMP statistics Key figure…
- EMA recommends authorisation of Rasonque for metastatic pancreatic cancerhace 37 d
EMA’s human medicines committee (CHMP) has recommended granting a marketing authorisation in the European Union for Rasonque (daraxonrasib), an oral treatment for adults with…
- Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 6-8 October 2026hace 43 d
CVMP opinions on veterinary medicinal productsThe Committee adopted a positive opinion, in exceptional circumstances, for a marketing authorisation for Bovilis Lumpyvax (lumpy…
- Clinical trial applications advice pilot becomes permanenthace 44 d
The Accelerating Clinical Trials in the EU (ACT EU) advice pilot, which helps sponsors prepare clinical trial applications, will become a permanent initiative from January 2027.…
- Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28 September - 1 Octoberhace 51 d
At its monthly meeting, EMA’s safety committee (PRAC) carried out its broad range of responsibilities to manage the safety of medicines, including the assessment of safety…, Agenda Agenda of the PRAC…
- Advice on ‘end-of-year’ submission dates for type I variations in 2026hace 51 d
Marketing authorisation holders wishing to receive an outcome in 2026 should submit type IA annual updates, individual type IA and type IAIN variations, and super-groupings…
Los comunicados más recientes de esta fuente se transmiten en vivo para los miembros de PPN World.
Preguntas frecuentes
¿Cómo seguir los comunicados de European Medicines Agency (EMA) — News en tiempo real?+
¿Con qué frecuencia se recogen los comunicados de European Medicines Agency (EMA) — News?+
¿Qué tipo de comunicados publica European Medicines Agency (EMA) — News?+
Feeds relacionados
- U.S. FDA
- UK Department of Health & Social Care
- NSW Minister for Health Media Releases
- U.S. CDC
- Inserm — Salle de presse
- Anses — Sécurité sanitaire (France)
- Ministério da Saúde (Brasil)
- Ministry of Health, Labour and Welfare Japan (MHLW)
- U.S. Department of Veterans Affairs (VA News)
- Statistics Canada — The Daily: Health